keyword
https://read.qxmd.com/read/38347465/influence-of-metabolic-state-and-body-composition-on-the-action-of-pharmacological-treatment-of-migraine
#1
REVIEW
Noor Bruijn, Romy van Lohuizen, Malgorzata Boron, Mira Fitzek, Francesca Gabriele, Giada Giuliani, Laura Melgarejo, Pavel Řehulka, Gabriele Sebastianelli, Paul Triller, Simone Vigneri, Behiye Özcan, Antoinette Maassen van den Brink
Migraine is a disabling neurovascular disorder among people of all ages, with the highest prevalence in the fertile years, and in women. Migraine impacts the quality of life of affected individuals tremendously and, in addition, it is associated with highly prevalent metabolic diseases, such as obesity, diabetes mellitus and thyroid dysfunction. Also, the clinical response to drugs might be affected in patients with metabolic disease due to body composition and metabolic change. Therefore, the efficacy of antimigraine drugs could be altered in patients with both migraine and metabolic disease...
February 13, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38307655/menstrually-associated-migraine
#2
REVIEW
Eleonora De Matteis, Raffaele Ornello, Simona Sacco
Menstrually related migraine is a disabling condition affecting 35% to 54% females with migraine during their fertile years. The International Headache Classification distinguishes menstrually related migraine from pure menstrual migraine based on the occurrence of the attacks even outside the perimenstrual periods. Hormonal fluctuations are the main driver for the disease in subjects with genetic susceptibility and alterations of brain structures and connectivity. Menstrually related attacks are often particularly severe and disabling requiring proper management...
2024: Handbook of Clinical Neurology
https://read.qxmd.com/read/36454715/cgrp-physiology-pharmacology-and-therapeutic-targets-migraine-and-beyond
#3
REVIEW
Andrew F Russo, Debbie L Hay
Calcitonin gene-related peptide (CGRP) is a neuropeptide with diverse physiological functions. Its two isoforms (α and β) are widely expressed throughout the body in sensory neurons as well as in other cell types, such as motor neurons and neuroendocrine cells. CGRP acts via at least two G protein-coupled receptors that form unusual complexes with receptor activity-modifying proteins. These are the CGRP receptor and the AMY1 receptor; in rodents, additional receptors come into play. Although CGRP is known to produce many effects, the precise molecular identity of the receptor(s) that mediates CGRP effects is seldom clear...
April 1, 2023: Physiological Reviews
https://read.qxmd.com/read/36200786/migraine-and-infertility-merging-concepts-in-women-s-reproductive-health-a-narrative-review
#4
REVIEW
Jasmin Harpe, Carolyn Bernstein, Andrea Harriott
OBJECTIVE: The objective is to examine issues around treating infertility in patients with migraine. BACKGROUND: Women outnumber men in migraine diagnosis with a 3:1 ratio; the disease is commonly expressed in women of child-bearing age and is influenced by changes in circulating hormones. Infertility is also common, and the use of treatment options, such as assisted reproductive technology, have expanded exponentially in recent years. METHODS: We summarized the literature around the effect of infertility treatments on headache in the general population and migraine population...
October 6, 2022: Headache
https://read.qxmd.com/read/36126006/evidence-based-contraception-common-questions-and-answers
#5
JOURNAL ARTICLE
Scott L Paradise, Corinne A Landis, David A Klein
Primary care clinicians are uniquely situated to reduce unintended pregnancy in the context of a patient's medical comorbidities, social circumstance, and gender identity. New evidence regarding contraception use has emerged in recent years. The copper intrauterine device is the most effective option for emergency contraception, with similar effectiveness found for the levonorgestrel-releasing intrauterine system, 52 mg, and both offer extended future contraception. Ulipristal given within 120 hours after unprotected intercourse is the most effective oral emergency contraceptive...
September 2022: American Family Physician
https://read.qxmd.com/read/35673942/women-with-polycystic-ovary-syndrome-are-burdened-with-multimorbidity-and-medication-use-independent-of-body-mass-index-at-late-fertile-age-a-population-based-cohort-study
#6
JOURNAL ARTICLE
Linda Kujanpää, Riikka K Arffman, Paula Pesonen, Elisa Korhonen, Salla Karjula, Marjo-Riitta Järvelin, Stephen Franks, Juha S Tapanainen, Laure Morin-Papunen, Terhi T Piltonen
INTRODUCTION: This population-based follow-up study investigated the comorbidities, medication use, and healthcare services among women with polycystic ovary syndrome (PCOS) at age 46 years. MATERIAL AND METHODS: The study population derived from the Northern Finland Birth Cohort 1966 and consisted of women reporting oligo/amenorrhea and hirsutism at age 31 years and/or a PCOS diagnosis by age 46 years (n = 246) and controls without PCOS symptoms or diagnosis (n = 1573), referred to as non-PCOS women...
July 2022: Acta Obstetricia et Gynecologica Scandinavica
https://read.qxmd.com/read/35514537/insights-from-genomic-studies-on-the-role-of-sex-steroids-in-the-aetiology-of-endometriosis
#7
REVIEW
Philippa T K Saunders
Endometriosis is a chronic neuro-inflammatory disorder the defining feature of which is the growth of tissue (lesions) that resembles the endometrium outside the uterus. Estimates of prevalence quote rates of ~10% of women of reproductive age, equating to at least 190 million women world-wide. Genetic, hormonal and immunological factors have all been proposed as contributing to risk factors associated with the development of lesions. Twin studies report the heritable component of endometriosis as ~50%. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) that appear over-represented in patients with endometriosis, particularly those with more extensive disease (stage III/IV)...
April 1, 2022: Reproduction & fertility
https://read.qxmd.com/read/33973648/selective-oestrogen-receptor-modulators-serms-for-endometriosis
#8
JOURNAL ARTICLE
Maaike Ht van Hoesel, Ya Li Chen, Ai Zheng, Qi Wan, Selma M Mourad
BACKGROUND: Endometriosis is defined as the presence of endometrial tissue outside the uterine cavity. This chronic and recurring condition occurs in women of reproductive age. It is a common cause of pain or infertility and can cause non-specific symptoms such as lower back pain, dyspareunia (pain during or after intercourse), and dysmenorrhoea (menstrual pain). Endometriosis is an oestrogen-dependent disease. Medical treatment aims to relieve symptoms and shrink lesions by suppressing the normal menstrual cycle...
May 11, 2021: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/33970361/effects-of-the-menstrual-cycle-on-neurological-disorders
#9
REVIEW
Hannah J Roeder, Enrique C Leira
PURPOSE OF REVIEW: The menstrual cycle involves recurrent fluctuations in hormone levels and temperature via neuroendocrine feedback loops. This paper reviews the impact of the menstrual cycle on several common neurological conditions, including migraine, seizures, multiple sclerosis, stroke, and Parkinson's disease. RECENT FINDINGS: The ovarian steroid hormones, estrogen and progesterone, have protean effects on central nervous system functioning that can impact the likelihood, severity, and presentation of many neurological diseases...
May 10, 2021: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/33876904/endometriosis-in-adolescent-and-young-women
#10
JOURNAL ARTICLE
Giuseppe Benagiano, Paola Bianchi, Sun-Wei Guo
Endometriosis in adolescence represents a specific variant of the disease with its own characteristics and, in some cases, even a possibly different pathogenesis. It has its own clinical presentation, diagnostic and therapeutic modalities. The condition is not rare as once thought and certainly deserves attention in view of increasing evidence of its likely progressive nature. Numerous theories for Its pathogenesis have been formulated and they have been divided into two main categories: the 'in-situ' and the 'transplantation' hypotheses...
April 20, 2021: Minerva obstetrics and gynecology
https://read.qxmd.com/read/33819673/-use-of-triptans-during-pregnancy
#11
JOURNAL ARTICLE
M Latour
Despite the widespread use of triptans in the treatment of migraine during pregnancy, questions relating to their vasoconstrictive properties have been raised following recent reports of rare fetal deaths and intrauterine growth restrictions. However, to date, analysis of these data does not allow to conclude to a direct effect of triptans, which remain a second line treatment of migraine attacks during pregnancy at any term and under normal conditions of use.
June 2021: Gynecologie, Obstetrique, Fertilite & Senologie
https://read.qxmd.com/read/33805838/menstrual-headache-in-women-with-chronic-migraine-treated-with-erenumab-an-observational-case-series
#12
JOURNAL ARTICLE
Raffaele Ornello, Ilaria Frattale, Valeria Caponnetto, Eleonora De Matteis, Francesca Pistoia, Simona Sacco
BACKGROUND: We aimed to assess the differences between menstrual and non-menstrual headache in women with chronic migraine treated with erenumab. METHODS: We included fertile women from a single center. Patients were defined as responders to erenumab if reporting a ≥50% decrease in monthly headache days, as compared to pre-treatment for more than half of the treatment period. Premenstrual days were defined as the two days preceding menstruation, while menstrual days were defined as the first three days of menstruation...
March 13, 2021: Brain Sciences
https://read.qxmd.com/read/33776441/patterns-of-migraine-in-postmenopausal-women-a-systematic-review
#13
REVIEW
Raffaele Ornello, Valeria Caponnetto, Ilaria Frattale, Simona Sacco
INTRODUCTION: Migraine prevalence is higher in fertile than in postmenopausal women. However, few literature data are available on the prevalence and characteristics of migraine after the menopause and on the effect of hormones in postmenopausal women with migraine. METHODS: We performed a systematic literature review of studies available on Scopus and Web of Science from the beginning off indexing until October 18th, 2020. We included both randomized trials and observational studies...
2021: Neuropsychiatric Disease and Treatment
https://read.qxmd.com/read/32768088/migraine-and-other-headache-disorders-in-pregnancy
#14
REVIEW
Daphne S van Casteren, Antoinette Maassen van den Brink, Gisela M Terwindt
Migraine prevalence is three times higher in women than in men during fertile years, which is mainly due to sex hormone differences. The majority of women suffering from migraine without aura report improvement of their migraine attacks during pregnancy. Migraine attacks with aura can also improve during pregnancy, but more often remain the same or worsen. Anovulation caused by lactation is generally associated with a decrease in migraine attacks in breastfeeding women. This chapter describes the current knowledge on acute and prophylactic treatment options of migraine and other primary headache disorders during pregnancy and lactation...
2020: Handbook of Clinical Neurology
https://read.qxmd.com/read/32699959/heart-malformation-is-an-early-response-to-valproic-acid-in-developing-zebrafish
#15
JOURNAL ARTICLE
Venugopalan Rajesh, Natarajan Deepan, Vijayakumar Anitha, Duraisamy Kalaiselvan, Subramanian Jayaseelan, Palanivel Sivakumar, Vellaiyachamy Ganesan
Valproic acid (VPA) is a branched short-chain fatty acid primarily used in epilepsy, but is also used in bipolar disorder, migraine, and psychotic disorders. Despite its wide range of use, it is a teratogen resulting in various congenital abnormalities. Although a large number of scientific studies evidenced the teratogenic effects, there are limited data on embryonic exposure to VPA at specific or different stages of early embryogenesis. Based on this, the present study was planned to investigate the embryonic exposure to VPA at specific and different hours post fertilization (hpf) in zebrafish embryonic model...
July 22, 2020: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/32646963/challenges-to-successful-research-careers-in-neurology-how-gender-differences-may-play-a-role
#16
REVIEW
Mia T Minen, Emily F Law, Andrea Harriott, Elizabeth K Seng, Jennifer Hranilovich, Christina L Szperka, Rebecca Erwin Wells
There has been a substantial rise in the number of women pursuing careers in neurology. However, research has shown that women in neurology have high rates of burnout with gender disparities in burnout and attrition in the field. Recently, there was a call from the National Institutes of Health (NIH), including the National Institute of Neurological Disorders and Stroke (NINDS), asking for input on factors that may limit or discourage grant applications from women. As the recipients of the highly coveted NIH career mentored awards (K-awards) in headache medicine, we applaud the NIH for asking for gender specific feedback and for raising awareness of research showing that female faculty on the Research Track are at increased risk of departure...
July 9, 2020: Neurology
https://read.qxmd.com/read/32588652/serum-levels-of-allopregnanolone-progesterone-and-testosterone-in-menstrually-related-and-postmenopausal-migraine-a-cross-sectional-study
#17
JOURNAL ARTICLE
Cecilia Rustichelli, Elisa Bellei, Stefania Bergamini, Emanuela Monari, Carlo Baraldi, Flavia Lo Castro, Aldo Tomasi, Anna Ferrari
BACKGROUND: Reduced blood or cerebrospinal fluid levels of allopregnanolone are involved in menstrual cycle-linked CNS disorders, such as catamenial epilepsy. This condition, like menstrually-related migraine, is characterized by severe, treatment-resistant attacks. We explored whether there were differences in allopregnanolone, progesterone and testosterone serum levels between women with menstrually-related migraine (MM, n = 30) or postmenopausal migraine without aura who had suffered from menstrually-related migraine during their fertile age (PM, n = 30) and non-headache control women in fertile age (FAC, n = 30) or post-menopause (PC, n = 30)...
October 2020: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/32106612/anti-inflammatory-and-antioxidant-properties-of-the-ethanol-extract-of-clerodendrum-cyrtophyllum-turcz-in-copper-sulfate-induced-inflammation-in-zebrafish
#18
JOURNAL ARTICLE
Thu Hang Nguyen, Hong Diep Le, Thanh Nguyen Thi Kim, Hai Pham The, Thi Mai Nguyen, Valérie Cornet, Jérôme Lambert, Patrick Kestemont
Oxidative stress and inflammation are commonly present in many chronic diseases. These responses are closely related to pathophysiological processes. The inflammatory process can induce oxidative stress and vice versa through the activation of multiple pathways. Therefore, agents with antioxidant and/or anti-inflammatory activities are very useful in the treatment of many pathologies. Clerodendrum cyrthophyllum Turcz, a plant belonging to the Verbenaceae family, is used in Vietnamese traditional medicine for treating migraine, hypertension, inflammation of the throat, and rheumatic arthritis...
February 25, 2020: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/31970392/population-based-data-at-ages-31-and-46-show-decreased-hrqol-and-life-satisfaction-in-women-with-pcos-symptoms
#19
JOURNAL ARTICLE
Salla Karjula, Laure Morin-Papunen, Stephen Franks, Juha Auvinen, Marjo-Riitta Järvelin, Juha S Tapanainen, Jari Jokelainen, Jouko Miettunen, Terhi T Piltonen
CONTEXT: Polycystic ovary syndrome (PCOS) is associated with decreased health-related quality of life (HRQoL), but longitudinal data beyond the reproductive years are lacking, and the impact of isolated PCOS symptoms is unclear. OBJECTIVE: To study generic HRQoL using the 15D questionnaire, life satisfaction, and self-reported health status in women with PCOS symptoms at ages 31 and 46 years. DESIGN: A longitudinal assessment using the Northern Finland Birth Cohort 1966...
June 1, 2020: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/31738897/analgesic-use-at-ovulation-and-implantation-and-human-fertility
#20
JOURNAL ARTICLE
Anne Marie Z Jukic, Ponnu Padiyara, Michael B Bracken, D Robert McConnaughey, Anne Z Steiner
BACKGROUND: Studies investigating the effects of pain-relieving medication use on conceiving a pregnancy have shown conflicting results. Furthermore, no previous study has examined medication use around ovulation or implantation and the associations with the probability of conception, fecundability. OBJECTIVE: The objective of the study was to explore the association between fecundability and analgesic use in 3 different menstrual cycle windows (preovulation, periovulation, and implantation) as well as across the entire menstrual cycle...
May 2020: American Journal of Obstetrics and Gynecology
keyword
keyword
97391
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.